PTH and abnormal mineralization disorder: Although many treatment approaches are available, remarkable proportions of patients still present inappropriate serum levels of parathyroid hormone (PTH), phosphate and calcium, often reaching far beyond what is recommended by the guidelines for the treatment of Chronic Kidney Disease Mineral Bone Disorder (CKD-MBD) [1, 4–6].